A recombinant vaccine for Theileria parva
The Development of a recombinant Theileria parva vaccine is discussed under the following headings: mechanisms of protection against ECF [East Coast fever]; cloning and expression of p67; immunization and challenge of cattle; interpretation of immunization and challenge data.
| Autores principales: | , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
Springer
1994
|
| Materias: | |
| Acceso en línea: | https://hdl.handle.net/10568/50104 |
Ejemplares similares: A recombinant vaccine for Theileria parva
- Experiences with immunization against Theileria parva using p67, a sporozoite surface antigen
- Protective immune mechanisms against Theileria parva: Evolution of vaccine development strategies
- Subunit vaccine based on the p67 major surface protein of Theileria parva sporozoites reduces severity of infection derived from field tick challenge
- Live vaccines for Theileria parva: deployment in eastern, Central and Southern Africa. Proceedings of an FAO/OAU-IBAR/ILRI workshop
- Characterization of an insect cell-derived Theileria parva sporozoite vaccine antigen and immunogenicity in cattle
- Vaccines against Theileria parva